| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| oncology endpoints fda guidance | 1.44 | 0.3 | 8315 | 56 | 31 |
| oncology | 1.59 | 0.9 | 2937 | 15 | 8 |
| endpoints | 0.65 | 0.4 | 2267 | 78 | 9 |
| fda | 0.67 | 0.7 | 9725 | 87 | 3 |
| guidance | 0.48 | 0.3 | 7003 | 57 | 8 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| oncology endpoints fda guidance | 0.7 | 0.9 | 289 | 30 |
| oncology clinical trial endpoints fda | 1.28 | 0.8 | 2788 | 95 |
| fda guidance multiple endpoints | 1.78 | 0.4 | 2500 | 43 |
| fda guidance on clinical trial endpoints | 1.91 | 0.1 | 3992 | 58 |
| fda endpoints in cancer trials | 1.36 | 0.4 | 2298 | 72 |
| clinical endpoints in oncology | 1.86 | 0.2 | 1434 | 33 |
| fda guidance combination oncology | 1.74 | 0.2 | 5664 | 57 |
| co-primary endpoints fda guidance | 1.63 | 0.7 | 707 | 60 |
| oncology clinical trial endpoints | 1.9 | 1 | 2479 | 95 |
| endpoints in oncology clinical trials | 0.52 | 0.7 | 6081 | 24 |
| clinical trial endpoints fda guidelines | 1.05 | 0.8 | 1876 | 90 |
| endpoints in oncology clinical trials ppt | 0.84 | 0.3 | 1843 | 74 |
| fda guidance oncology trial design | 1.78 | 0.1 | 9622 | 74 |
| clinical trial endpoints fda | 0.34 | 1 | 2976 | 87 |
| fda office of oncology products | 0.32 | 1 | 7866 | 30 |
| fda multiple endpoints in clinical trials | 1.35 | 0.8 | 7075 | 72 |
| fda division of oncology | 1.52 | 0.3 | 223 | 20 |
| fda office of oncology drugs | 0.17 | 0.6 | 6681 | 17 |
| fda guidance clinical pharmacology | 0.91 | 0.7 | 6316 | 14 |
| fda center for oncology excellence | 0.39 | 0.8 | 340 | 92 |
